A detailed history of Swarthmore Group Inc transactions in Pfizer Inc stock. As of the latest transaction made, Swarthmore Group Inc holds 9,181 shares of PFE stock, worth $241,460. This represents 0.19% of its overall portfolio holdings.

Number of Shares
9,181
Previous 122,500 92.51%
Holding current value
$241,460
Previous $6.34 Million 92.42%
% of portfolio
0.19%
Previous 1.62%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 20, 2022

SELL
$46.53 - $55.17 $5.27 Million - $6.25 Million
-113,319 Reduced 92.51%
9,181 $481,000
Q1 2022

Apr 11, 2022

SELL
$45.75 - $56.69 $51,834 - $64,229
-1,133 Reduced 0.92%
122,500 $6.34 Million
Q4 2021

Jan 19, 2022

BUY
$41.32 - $61.25 $5.11 Million - $7.57 Million
123,633 New
123,633 $7.3 Million
Q1 2018

Apr 12, 2018

SELL
$31.91 - $37.02 $392,493 - $455,346
-12,300 Closed
0 $0
Q4 2017

Jan 18, 2018

SELL
$33.26 - $35.29 $26,608 - $28,232
-800 Reduced 6.11%
12,300 $446,000
Q3 2017

Oct 11, 2017

BUY
$31.0 - $34.15 $406,100 - $447,365
13,100
13,100 $468,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Swarthmore Group Inc Portfolio

Follow Swarthmore Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swarthmore Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Swarthmore Group Inc with notifications on news.